This study is looking at how continuous glucose monitors (CGMs) like FreeStyle Libre 2 or Libre 3+ can help people with Type 2 Diabetes manage their blood sugar. You might be able to join if you have Type 2 Diabetes, an A1c (a measure of average blood sugar over 2-3 months) of 8% or higher, and a compatible smartphone. The study wants to see if using a CGM with guidance from a pharmacist helps lower A1c levels more than just using a regular blood sugar meter with pharmacist guidance. The study will last for 12 weeks. We don't know the current enrollment status.

Study design

This is an observational pilot study planning to include 40 participants. It compares a group using continuous glucose monitoring with pharmacist support to a group using only a glucometer with pharmacist support.

What's involved

If you join, you will be enrolled for 12 weeks. You will use either a FreeStyle Libre 2/Libre 3+ continuous glucose monitor or a glucometer for self-monitoring.

Compensation

Not stated in the trial record.

Follow-up

Your A1c will be measured at the beginning and again at the end of the 12-week study period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.